Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Personalized medicine in context
T2 - social science perspectives
AU - Tutton, Richard
AU - Jamie, Kimberly
PY - 2013
Y1 - 2013
N2 - In the 1990s, the scientific and popular press heralded the emergence of a new paradigm in drug discovery and development called pharmacogenomics (pgmx). As well as capturing the interest of scientists, policymakers and journalists, the field of personalized medicine has also been of immense interest to social scientists who research new innovations in health and biomedicine. This article reviews existing social science research on pgmx. It considers work on mapping industry involvement in pgmx; the dynamics of clinical adoption and the challenges of pgmx testing becoming a standard healthcare service; and patient and public perspectives on pgmx. In conclusion, the article reflects on the future research agenda.
AB - In the 1990s, the scientific and popular press heralded the emergence of a new paradigm in drug discovery and development called pharmacogenomics (pgmx). As well as capturing the interest of scientists, policymakers and journalists, the field of personalized medicine has also been of immense interest to social scientists who research new innovations in health and biomedicine. This article reviews existing social science research on pgmx. It considers work on mapping industry involvement in pgmx; the dynamics of clinical adoption and the challenges of pgmx testing becoming a standard healthcare service; and patient and public perspectives on pgmx. In conclusion, the article reflects on the future research agenda.
U2 - 10.1016/j.ddstr.2013.05.003
DO - 10.1016/j.ddstr.2013.05.003
M3 - Journal article
VL - 10
SP - e183-e187
JO - Drug Discovery Today: Therapeutic Strategies
JF - Drug Discovery Today: Therapeutic Strategies
SN - 1740-6773
IS - 4
ER -